This early-phase trial tests whether adding two experimental DNA vaccines (INO-5401 and INO-9012) and an immunotherapy drug (cemiplimab) to standard radiation and chemotherapy is safe and helps people with newly-diagnosed glioblastoma, a fast-growing brain cancer. About 52 adults…
Phase: PHASE1, PHASE2 • Sponsor: Inovio Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC